4//SEC Filing
Stephan Dietrich A 4
Accession 0001104659-22-001691
CIK 0001173281other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:45 PM ET
Size
8.2 KB
Accession
0001104659-22-001691
Insider Transaction Report
Form 4
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common Stock
2021-12-31$0.00/sh+42,250$42→ 66,775 total - Exercise/Conversion
Stock option (right to buy)
2021-12-31$0.00/sh−42,250$42→ 3,269,680 totalExercise: $0.00From: 2019-07-12Exp: 2028-12-31→ Common Stock (42,250 underlying)
Holdings
- 1,273,819(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by the reporting person as a tenant by the entirety with his spouse.
- [F2]These shares are held in an irrevocable trust in which the spouse of the reporting person is the investment trustee, and the spouse and the descendants of the reporting person are its beneficiaries, and another irrevocable trust in which the reporting person is the investment trustee, and the reporting person and the descendants of the reporting person's spouse are its beneficiaries.
Documents
Issuer
NeuBase Therapeutics, Inc.
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001774588
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:45 PM ET
- Size
- 8.2 KB